Item 1. Financial Statements
ITEM 1. FINANCIAL STATEMENTS
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
June 30, 2024
December 31, 2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$ 12,391,431
$ 11,899,574
Certificates of deposit
22,216
72,898
Accounts receivable, net
1,393,760
625,256
Inventories, net
462,354
1,019,154
Prepaid expenses and other current assets
291,229
92,369
Current assets held for sale (Note 11)
50,798
366,955
Total current assets
14,611,788
14,076,206
Properties, plants and equipment, net
7,798,594
7,765,045
Restricted cash for reclamation bonds
55,060
55,061
Other assets
20,217
18,098
Non-current assets held for sale (Note 11)
6,443,581
6,180,585
Total assets
$ 28,929,240
$ 28,094,995
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
$ 544,100
$ 330,147
Accrued liabilities
157,001
109,341
Accrued liabilities - directors
161,249
124,810
Royalties payable
113,917
153,429
Long-term debt, current portion
129,967
28,443
Current liabilities held for sale (Note 11)
145,930
151,288
Total current liabilities
1,252,164
897,458
Long-term debt, net of current portion
262,127
-
Stock payable to directors
38,542
38,542
Asset retirement obligations
1,138,102
1,101,561
Non-current liabilities held for sale (Note 11)
536,466
536,466
Total liabilities
3,227,401
2,574,027
COMMITMENTS AND CONTINGENCIES (Note 8 and 11)
STOCKHOLDERS' EQUITY
Preferred stock $ 0.01 par value, 10,000,000 shares authorized:
Series A: 0 shares issued and outstanding
-
-
Series B: 750,000 shares issued and outstanding (liquidation preference $ 971,250 and $ 967,500 , respectively)
7,500
7,500
Series C: 177,904 shares issued and outstanding (liquidation preference $ 97,847 both years)
1,779
1,779
Series D: 0 shares issued and outstanding
-
-
Common stock, $ 0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares issued and outstanding, respectively
1,084,389
1,076,472
Additional paid-in capital
64,146,766
63,853,836
Accumulated deficit
( 39,538,595 )
( 39,418,619 )
Total stockholders' equity
25,701,839
25,520,968
Total liabilities and stockholders' equity
$ 28,929,240
$ 28,094,995
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
3
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
For the three months ended
For the six months ended
June 30, 2024
June 30, 2023
June 30, 2024
June 30, 2023
REVENUES
$ 2,813,780
$ 2,265,117
$ 5,645,170
$ 4,475,961
COST OF REVENUES
1,905,139
1,878,558
3,913,625
3,694,559
GROSS PROFIT
908,641
386,559
1,731,545
781,402
OPERATING EXPENSES:
General and administrative
477,366
247,419
932,760
388,690
Salaries and benefits
285,359
145,412
526,964
273,104
Professional fees
221,529
191,063
398,686
237,067
Loss on disposal of property, plant and equipment
-
-
17,494
-
Other operating expenses
137,991
-
137,991
-
TOTAL OPERATING EXPENSES
1,122,245
583,894
2,013,895
898,861
LOSS FROM OPERATIONS
( 213,604 )
( 197,335 )
( 282,350 )
( 117,459 )
OTHER INCOME (EXPENSE):
Interest and investment income
151,921
167,781
302,772
290,153
Trademark and licensing income
8,360
11,381
14,728
18,906
Other miscellaneous income (expense)
( 2,381 )
( 4,859 )
( 4,753 )
78,749
TOTAL OTHER INCOME
157,900
174,303
312,747
387,808
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
( 55,704 )
( 23,032 )
30,397
270,349
Income tax expense
-
-
-
-
INCOME (LOSS) FROM CONTINUING OPERATIONS
( 55,704 )
( 23,032 )
30,397
270,349
Discontinued operations:
Income (loss) from discontinued operations before income taxes
258,496
( 313,433 )
( 150,373 )
( 1,413,798 )
Income tax expense
-
-
-
-
Income (loss) from discontinued operations (Note 11)
258,496
( 313,433 )
( 150,373 )
( 1,413,798 )
Net income (loss)
202,792
( 336,465 )
( 119,976 )
( 1,143,449 )
Preferred dividends
( 1,875 )
( 1,875 )
( 3,750 )
( 3,750 )
Net income (loss) available to common stockholders
$ 200,917
($ 338,340 )
($ 123,726 )
($ 1,147,199 )
Basic and diluted earnings per common share:
Income (loss) from continuing operations
$nil
$nil
$nil
$nil
Income (loss) from discontinued operations
$nil
$nil
$nil
$ ( 0.01 )
Net income (loss)
$nil
$nil
$nil
$ ( 0.01 )
Weighted average shares outstanding:
Basic
108,438,984
107,647,317
108,173,645
107,504,628
Diluted
108,943,126
107,647,317
108,425,716
107,504,628
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
4
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
For the three and six months ended June 30, 2024 and 2023
Total Preferred Stock
Common stock
Additional
Paid In
Shares
to be
returned
to
Accumulated
Shares
Amount
Shares
Amount
Capital
treasury
Deficit
Total
Balances, December 31, 2022
2,620,576
$ 26,205
106,373,341
$ 1,063,732
$ 64,052,630
($202,980)
($33,070,332)
$ 31,869,255
Conversion of Preferred Series D to common stock
( 1,692,672 )
( 16,926 )
1,692,672
16,927
( 1 )
-
-
-
Common stock buyback and retirement
-
-
( 418,696 )
( 4,187 )
( 198,793 )
202,980
-
-
Net loss
-
-
-
-
-
-
( 806,984 )
( 806,984 )
Balances, March 31, 2023
927,904
$ 9,279
107,647,317
$ 1,076,472
$ 63,853,836
-
($33,877,316)
$ 31,062,271
Net loss
-
-
-
-
-
-
( 336,465 )
( 336,465 )
Balances, June 30, 2023
927,904
$ 9,279
107,647,317
$ 1,076,472
$ 63,853,836
$ -
( 34,213,781 )
$ 30,725,806
Balances, December 31, 2023
927,904
$ 9,279
107,647,317
$ 1,076,472
$ 63,853,836
-
($39,418,619)
$ 25,520,968
Share-based compensation
-
-
791,667
7,917
198,008
-
-
205,925
Net loss
-
-
-
-
-
-
( 322,768 )
( 322,768 )
Balances, March 31, 2024
927,904
$ 9,279
108,438,984
$ 1,084,389
$ 64,051,844
-
$ ( 39,741,387 )
$ 25,404,125
Share-based compensation
-
-
-
-
94,922
-
-
94,922
Net Income
-
-
-
-
-
-
202,792
202,792
Balances, June 30, 2024
927,904
$ 9,279
108,438,984
$ 1,084,389
$ 64,146,766
$ -
$ ( 39,538,595 )
$ 25,701,839
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
5
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the six months ended
June 30, 2024
June 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES OF CONTINUING OPERATIONS:
Net income from continuing operations
$ 30,397
$ 270,349
Adjustments to reconcile net income from continuing operations to net cash
provided (used) by operating activities of continuing operations:
Depreciation and amortization
220,633
154,458
Accretion of asset retirement obligation
36,541
750
Loss on disposal of property, plant, and equipment
17,494
-
Write down of inventory to net realizable value
10,501
-
Share-based compensation
300,847
-
Allowance for doubtful accounts on accounts receivable
( 14,258 )
43,560
Other non-cash items
( 16,106 )
( 13,621 )
Changes in operating assets and liabilities:
Accounts receivable
( 754,246 )
( 567,077 )
Inventories, net
546,299
( 265,804 )
Prepaid expenses and other current assets
( 198,860 )
( 240,225 )
Other assets
( 2,119 )
-
Accounts payable
213,953
( 253,580 )
Accrued liabilities
47,660
( 52,935 )
Accrued liabilities – directors
36,439
145,413
Royalties payable
( 39,512 )
( 389,716 )
Net cash provided (used) by operating activities of continuing operations
435,663
( 1,168,428 )
CASH FLOWS FROM INVESTING ACTIVITIES OF CONTINUING OPERATIONS:
Proceeds from redemption of certificates of deposit
50,682
-
Purchases of properties, plant, and equipment
( 150,721 )
( 1,195,534 )
Net cash used by investing activities of continuing operations
( 100,039 )
( 1,195,534 )
CASH FLOWS FROM FINANCING ACTIVITIES OF CONTINUING OPERATIONS:
Payments on dividends payable
-
( 787,730 )
Principal payments on long-term debt
( 39,071 )
( 46,370 )
Net cash used by financing activities of continuing operations
( 39,071 )
( 834,100 )
Net cash flows provided (used) by continuing operations
296,553
( 3,198,062 )
CASH FLOWS FROM DISCONTINUED OPERATIONS:
Net cash provided (used) by operating activities
195,303
( 2,023,067 )
Net cash used by investing activities
-
( 152,322 )
Net cash flows provided (used) by discontinued operations
195,303
( 2,175,389 )
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
491,856
( 5,373,451 )
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD
11,954,635
19,117,666
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD
$ 12,446,491
$ 13,744,215
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Common stock buyback and retirement
-
$ 202,980
Conversion of Preferred Series D to Common Stock
-
$ 16,927
Equipment purchased with note payable
$ 402,722
$ 0
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
6
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
NOTE 1 - NATURE OF OPERATIONS
United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover certain amounts of precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.
Developments in the Current Period
The Company has two subsidiaries in Mexico, US Antimony de Mexico, S.A. de C.V. (“USAMSA”) and Antimonio de Mexico, S.A. de C.V. (“ADM”). On March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary. The USAMSA subsidiary primarily includes the Company’s Madero antimony and precious metals plant in Parras de la Fuente Coahuila, Mexico and its Puerto Blanco antimony and precious metals plant in San Luis de la Paz Guanajuato, Mexico. The Company intends to sell its USAMSA subsidiary over the next year and has initiated an active search for buyers of its operations and/or assets. While the Company will maintain its existing Los Juarez mining claims and concessions in Mexico, which are included in our ADM subsidiary, there are presently no active operations at Los Juarez. See Note 11 for further information.
In May 2024, the Company made the decision to sell the personal residence it owns in Idaho that was previously used for management located near its Bear River Zeolite Company (“BRZ”) operation (“BRZ Home”). BRZ is a wholly-owned subsidiary of USAC. The Company also signed an agreement with a realtor in May 2024 to assist with the sale of its BRZ Home. An active search for a buyer began after signing the agreement with the realtor and the Company expects the BRZ Home to be sold sometime over the next year. See Note 11 for further information.
BRZ financed the purchase of a wheel loader in the second quarter of 2024. See Note 7 for further information.
NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2024, and its results of operations and cash flows for the three and six months ended June 30, 2024 and 2023. The Condensed Consolidated Balance Sheet as of December 31, 2023, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.
7
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on April 12, 2024.
This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements.
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company's consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions, which could have a material effect on the reported amounts of the Company's consolidated financial position and results of operations. Operating results for the three and six-month periods ended June 30, 2024, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2024.
Reclassifications
Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported.
Assets Held for Sale and Discontinued Operations
The Company classifies assets and liabilities to be sold ("Disposal Group") as held for sale in the period when all of the applicable criteria are met, including: (i) management commits to a plan to sell, (ii) the Disposal Group is available to sell in its present condition, (iii) there is an active program to locate a buyer, (iv) the Disposal Group is being actively marketed at a reasonable price in relation to its fair value, (v) significant changes to the plan to sell are unlikely, and (vi) the sale of the Disposal Group is generally probable of being completed within one year. Management performs an assessment at least quarterly or when events or changes in business circumstances indicate that a change in classification may be necessary.
Assets and liabilities held for sale are presented separately within the Condensed Consolidated Balance Sheets with any adjustments necessary to measure the Disposal Group at the lower of its carrying value or fair value less costs to sell. Depreciation of property and equipment are not recorded while these assets are classified as held for sale. For each period the Disposal Group remains classified as held for sale, its recoverability is reassessed and any necessary adjustments are made to its carrying value.
The Company categorizes the assets and liabilities of a Disposal Group, or business component, as discontinued operations once management commits to a plan to sell, the business segment is available for immediate sale, management has initiated a plan to sell at a price that is reasonable in relation to its fair value, management anticipates the sale will occur within one year, and it is unlikely that significant changes will be made to the plan to sell. In addition, the business component must be comprised of operations and cash flows that are clearly distinguished from the rest of the entity. The results of discontinued operations are aggregated and presented separately in the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations.
8
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Share-Based Compensation
The Company’s share-based awards consist of restricted stock units (“RSUs”) and stock options granted to employees and non-employee directors.
RSUs are stock awards entitling the award recipient to a specified number of shares of the Company’s common stock as the award vests. Each RSU granted includes a service-based vesting condition, which is the only vesting condition related to the RSU grants. The Company calculates the fair value of RSUs on the grant date using the closing market price of the Company’s common stock on the grant date. The Company recognizes the grant date fair value of RSUs as share-based compensation expense ratably over the requisite service period, other than RSUs or portions of RSUs that vest on the grant date, in which case the grant date fair value of that RSU or portion of RSU is recognized as share-based compensation expense on the grant date. The Company recognizes forfeitures as they occur.
Stock options grant award recipients the option to purchase a specified number of shares of the Company’s common stock at an exercise price per share specified in the grant agreement as the stock options vest. Stock option grants include either a service-based vesting condition or performance-based vesting conditions with a specified contractual term. The Company calculates the fair value of stock options on the grant date using the Black-Scholes option-pricing model, which requires the Company to make estimates and assumptions, such as expected volatility, expected term, and risk-free interest rate. Service and performance conditions are not considered in determining the award’s fair value on the grant date. The Company recognizes share-based compensation expense related to stock option awards from the grant date through the vesting date. For service-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably over the requisite service period. For performance-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably from the grant date through the vesting date based on the probability and timing of achieving the performance conditions. The Company recognizes forfeitures and expirations as they occur.
The expense related to employee and non-employee director share-based awards is recorded in “Salaries and benefits” and “General and administrative,” respectively, in the Condensed Consolidated Statements of Operations.
9
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Recent Accounting Pronouncements
Management does not believe that any recently issued but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, amending reportable segment disclosure requirements to include disclosure of incremental segment information on an annual and interim basis. Among the disclosure enhancements are new disclosures regarding significant segment expenses that are regularly provided to the chief operating decision-maker and included within each reported measure of segment profit or loss, as well as other segment items bridging segment revenue to each reported measure of segment profit or loss. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and for interim periods beginning January 1, 2025, and are applied retrospectively. Early adoption is permitted. We are currently evaluating the effect the updated standard will have on our consolidated financial statements and disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. We are currently evaluating the effect the updated standard will have on our consolidated financial statements and disclosures.
NOTE 3 – EARNINGS PER SHARE
Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through convertible preferred stock, stock options, RSUs, and warrants.
At June 30, 2024 and 2023, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive were as follows:
June 30, 2024
June 30, 2023
Warrants
12,346,215
12,346,215
Stock options and RSU awards
3,945,000
-
Total possible dilution
16,291,215
12,346,215
10
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
NOTE 4 – REVENUE RECOGNITION
Products consist of the following:
·
Antimony: includes antimony oxide, antimony metal, antimony trisulfide.
·
Zeolite: includes coarse and fine zeolite crushed in various sizes.
·
Precious metals: includes unrefined and refined gold and silver.
Sales of products for the three months ended June 30, 2024 and 2023 were as follows:
For the three months ended
June 30, 2024
June 30, 2023
Antimony product revenue
$ 1,814,778
$ 1,351,705
Zeolite product revenue
994,386
787,091
Precious metals product revenue
4,616
126,321
TOTAL REVENUES
$ 2,813,780
$ 2,265,117
Sales of products for the six months ended June 30, 2024 and 2023 were as follows:
For the six months ended
June 30, 2024
June 30, 2023
Antimony product revenue
$ 4,043,163
$ 2,964,344
Zeolite product revenue
1,597,391
1,269,184
Precious metals product revenue
4,616
242,433
TOTAL REVENUES
$ 5,645,170
$ 4,475,961
Domestic and foreign revenues for the three months ended June 30, 2024 and 2023 were as follows:
For the three months ended
June 30, 2024
June 30, 2023
Domestic revenues
$ 2,168,823
$ 1,814,987
Foreign revenues
644,957
450,130
TOTAL REVENUES
$ 2,813,780
$ 2,265,117
Domestic and foreign revenues for the six months ended June 30, 2024 and 2023 were as follows:
For the six months ended
June 30, 2024
June 30, 2023
Domestic revenues
$ 4,449,597
$ 3,584,434
Foreign revenues
1,195,573
891,527
TOTAL REVENUES
$ 5,645,170
$ 4,475,961
11
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
The Company’s trade accounts receivable balance related to contracts with customers was $ 1,393,760 at June 30, 2024 and $ 625,256 at December 31, 2023, net of an allowance for doubtful accounts related to trade accounts receivables of $ 256,955 and $ 271,212 at June 30, 2024 and December 31, 2023, respectively. The Company’s products do not involve any warranty agreements and product returns are not typical.
NOTE 5– INVENTORIES
Inventories at June 30, 2024 and December 31, 2023 consisted primarily of finished antimony metal and antimony oxide products, antimony ore and concentrates, and finished zeolite products. Inventories are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products and finished zeolite products costs primarily include direct materials, direct labor, overhead, depreciation, and freight. Inventories at June 30, 2024 and December 31, 2023 were as follows:
June 30, 2024
December 31, 2023
Antimony oxide inventory
$ 47,166
$ 252,927
Antimony metal inventory
12,361
237,429
Antimony ore and concentrates inventory
25,899
23,752
Total antimony inventory
85,426
514,108
Zeolite inventory
376,928
505,046
TOTAL INVENTORIES
$ 462,354
$ 1,019,154
At June 30, 2024 and December 31, 2023, inventories were valued at cost, except for the portion of inventory related to zeolite at June 30, 2024, which was valued at net realizable value because costs were greater than the amount the Company expected to receive on the sale of zeolite inventory. The adjustment to value inventory at net realizable value was $ 10,501 and $nil at June 30, 2024 and 2023, respectively.
Antimony oxide and metal inventory consisted of finished products held by the Company’s plant in Montana. Antimony ore and concentrates were held primarily at its plants in Montana and Mexico. The Company’s zeolite inventory consisted primarily of saleable zeolite material at the Company’s plant in Idaho.
12
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT
The major components of the Company’s properties, plants and equipment (“PP&E”) by segment at June 30, 2024 and December 31, 2023 were as follows:
June 30, 2024
Antimony Segment
Zeolite Segment
Precious Metals
USAC
Mexico
BRZ
Segment
TOTAL
Plant and equipment
$ 1,675,444
$ 79,001
$ 5,888,536
$ 234,174
$ 7,877,155
Buildings
243,248
11,970
1,705,893
-
1,961,111
Land and other
2,727,198
1,329,987
687,639
-
4,744,824
Construction in progress
-
-
-
-
-
PP&E, gross
$ 4,645,890
$ 1,420,958
$ 8,282,068
$ 234,174
$ 14,583,090
Accumulated depreciation
( 2,689,707 )
( 243,072 )
( 3,666,464 )
( 185,253 )
( 6,784,496 )
PP&E, net
$ 1,956,183
$ 1,177,886
$ 4,615,604
$ 48,921
$ 7,798,594
December 31, 2023
Antimony Segment
Zeolite Segment
Precious Metals
USAC
Mexico
BRZ
Segment
TOTAL
Plant and equipment
$ 1,675,444
$ 79,001
$ 5,336,808
$ 234,174
$ 7,325,427
Buildings
243,248
11,970
2,025,043
-
2,280,261
Land and other
2,727,198
1,329,987
687,639
-
4,744,824
Construction in progress
-
-
8,951
-
8,951
PP&E, gross
$ 4,645,890
$ 1,420,958
$ 8,058,441
$ 234,174
$ 14,359,463
Accumulated depreciation
( 2,661,719 )
( 235,024 )
( 3,524,130 )
( 173,545 )
( 6,594,418 )
PP&E, net
$ 1,984,171
$ 1,185,934
$ 4,534,311
$ 60,629
$ 7,765,045
NOTE 7 – LONG-TERM DEBT
Long-term debt at June 30, 2024 and December 31, 2023 was as follows:
June 30, 2024
December 31, 2023
Installment contract payable to Komatsu, bearing interest at 3.49%, payable in 36 monthly installments of $11,799 maturing May 2027; collateralized by the Komatsu Wheel Loader
$ 392,094
$ -
Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck
-
28,443
Total debt
392,094
28,443
Less current portion of debt
( 129,967 )
( 28,443 )
Long term portion of debt
$ 262,127
$ -
13
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
At June 30, 2024, principal payments on debt were due as follows:
Twelve months ending June 30,
Principal Payment
2025
$ 129,967
2026
134,577
2027
127,550
$ 392,094
NOTE 8 – COMMITMENTS AND CONTINGENCIES
The Company follows U.S. GAAP guidance in determining its accruals and disclosures with respect to loss contingencies and evaluates such accruals and contingencies for each reporting period. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a loss could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred.
Historically, from time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At June 30, 2024 and December 31, 2023, the Company had no accrued liabilities relating to such assessments. However, during the six months ended June 30, 2024, Bear River Zeolite Company (“BRZ”), a wholly owned subsidiary of the Company, received four significant and substantial citations from MSHA, all of which have been rectified by BRZ.
On a combined basis, BRZ pays royalties ranging from 8 % to 13 % on the sale of zeolite products. At June 30, 2024 and December 31, 2023, the Company had accrued royalties payable of $ 113,917 and $ 153,429 , respectively.
NOTE 9 – STOCKHOLDERS’ EQUITY
On January 25, 2023, the holders of 1,692,672 shares of Series D Preferred stock converted the preferred shares and the Company issued 1,692,672 shares of common stock. The Company also paid the holders $ 787,730 for cumulative dividends payable as declared on November 28, 2022. 1,590,672 shares of the 1,692,672 shares of Series D Preferred stock that were converted and $ 740,261 of the $ 787,730 of dividends paid related to the estate of John Lawrence, who was a prior President and Chairman of the Company.
On January 26, 2023, in conjunction with its share repurchase plan, the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980 .
14
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Share-based compensation
The Company had no equity awards outstanding during fiscal year 2023. During the six months ended June 30, 2024, stock option and RSU awards were granted in accordance with our 2023 Equity Incentive Plan, which was approved by the Company’s shareholders. The Company recognized $ 94,922 and $nil during the three months ended June 30, 2024 and 2023, respectively, and $ 300,847 and $nil during the six months ended June 30, 2024 and 2023, respectively, of share-based compensation expense arising from stock option and RSU grants as follows:
Three Months Ended June 30,
Six Months Ended June 30,
2024
2023
2024
2023
Share-based compensation expense:
Stock options
$ 47,558
$ -
$ 63,469
$ -
RSUs
47,364
-
237,378
-
Total share-based compensation expense
$ 94,922
$ -
$ 300,847
$ -
Stock options:
Stock options granted have either a 3 -year or 10 -year contractual term and are subject to either service or performance-based vesting conditions. The following table shows the annual weighted-average assumptions used to value options granted during the six months ended June 30, 2024:
Six Months Ended
Grant-Date Weighted-Average Assumptions
June 30, 2024
Expected term (in years)
3.9
Risk-free interest rate
4.3 %
Expected dividend yield
0.0 %
Expected volatility
140.4 %
Fair value per share of options granted
$ 0.17
Expected term – The expected term represents the period of time that options are expected to be outstanding. As the Company does not have sufficient historical exercise behavior, it uses the contractual term of the option for the expected term assumption.
Risk-free interest rate – The risk-free interest rate is based on the U.S. Treasury rate in effect at the time of the grant with an equivalent term approximating the expected term of the options.
Expected dividend yield —The Company bases the expected dividend yield assumption on the fact that it has never paid cash dividends and has no present intention to pay cash dividends.
Expected volatility – The expected volatility is based on the historical volatility of our stock price over the expected term of the stock option.
15
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Activity with respect to stock options is summarized as follows:
Weighted-Average
Weighted-
Remaining
Aggregate
Average
Contractual
Intrinsic
Shares
Exercise Price
Term (in years)
Value
Options outstanding, December 31, 2023
-
n/a
n/a
n/a
Granted
3,900,000
$ 0.22
n/a
n/a
Exercised
-
n/a
n/a
n/a
Forfeited
-
n/a
n/a
n/a
Expired
-
n/a
n/a
n/a
Options outstanding, June 30, 2024
3,900,000
$ 0.22
3.6
$ 450,000
Nonvested options, June 30, 2024
3,900,000
$ 0.22
3.6
$ 450,000
Vested and exercisable options, June 30, 2024
-
n/a
n/a
n/a
At June 30, 2024, total unrecognized share-based compensation expense related to stock options was $ 606,531 , which is expected to be recognized over a weighted-average remaining period of 4.0 years.
Restricted stock units:
Activity with respect to RSUs is summarized as follows:
Weighted-Average
Grant-Date
Shares
Fair Value
Nonvested shares at December 31, 2023
-
n/a
Granted
2,670,000
$ 0.22
Vested
( 791,667 )
$ 0.22
Forfeited
-
n/a
Nonvested shares at June 30, 2024
1,878,333
$ 0.23
At June 30, 2024, total unrecognized share-based compensation expense related to RSUs was $ 363,172 , which is expected to be recognized over a weighted-average remaining period of 1.9 years.
16
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Common stock warrants
No warrants were issued, expired, or exercised during the six months ended June 30, 2024 and 2023.
The composition of the Company’s warrants outstanding at June 30, 2024 and 2023 was as follows:
Number of warrants
Exercise Price
Expiration Date
Remaining life (years)
2,285,715
$ 0.46
7/31/2025
1.08
804,000
$ 0.46
1/27/2026
1.58
7,650,000
$ 0.85
8/3/2026
2.09
1,606,500
$ 0.85
2/1/2026
1.59
12,346,215
NOTE 10 – BUSINESS SEGMENTS
The Company is organized and managed with four business segments, which represent our operating units: United States antimony operations, Mexico antimony operations, precious metals recovery and United States zeolite operations. See Note 11 for the Mexico discontinued operations that are excluded from business segments.
Total assets by segment at June 30, 2024 and December 31, 2023 were as follows:
Total Assets, Excluding Discontinued Operations
June 30, 2024
December 31, 2023
Antimony segment:
United States total assets
$ 15,568,968
$ 14,769,408
Mexico total assets
1,259,154
1,211,319
Subtotal antimony segment
$ 16,828,122
$ 15,980,727
Precious metals segment:
United States total assets
$ 48,921
$ 92,718
Mexico total assets
-
-
Subtotal precious metals segment
$ 48,921
$ 92,718
Zeolite segment
5,557,818
5,474,010
Total assets, excluding discontinued operations
$ 22,434,861
$ 21,547,455
17
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Total capital expenditures by segment for the three and six months ended June 30, 2024 and 2023 were as follows:
Capital expenditures, Excluding Discontinued Operations
For the three months ended
For the six months ended
June 30, 2024
June 30, 2023
June 30, 2024
June 30, 2023
Antimony segment:
United States capital expenditures
$ -
$ 58,299
$ -
$ 61,849
Mexico capital expenditures
-
-
-
-
Subtotal antimony segment
$ -
$ 58,299
$ -
$ 61,849
Precious metals segment
-
-
-
-
Zeolite segment
98,008
636,033
150,721
$ 1,133,685
Total capital expenditures, excluding discontinued operations
$ 98,008
$ 694,332
$ 150,721
$ 1,195,534
The zeolite segment’s capital expenditures for the three and six months ended June 30, 2024 excludes $402,722 related to a wheel loader purchased with a note payable.
Selected segment operational information for the three and six months ended June 30, 2024 and 2023 were as follows:
Segment Operations, Excluding Discontinued Operations
Antimony
Antimony
Total
Precious
For the three months ended June 30, 2024
USA
Mexico
Antimony
Metals
Zeolite
Total
Total revenues
$ 1,814,778
$ 0
$ 1,814,778
$ 4,616
$ 994,386
$ 2,813,780
Depreciation and amortization
14,047
4,024
18,071
5,855
90,560
114,486
Income (loss) from operations
$ ( 37,909 )
$ ( 26,196 )
$ ( 64,105 )
$ ( 1,239 )
$ ( 148,260 )
$ ( 213,604 )
Other income
157,900
Income tax expense
-
Loss from continuing operations
$ ( 55,704 )
Segment Operations, Excluding Discontinued Operations
Antimony
Antimony
Total
Precious
For the three months ended June 30, 2023
USA
Mexico
Antimony
Metals
Zeolite
Total
Total revenues
$ 1,351,705
$ 0
$ 1,351,705
$ 126,321
$ 787,091
$ 2,265,117
Depreciation and amortization
10,361
4,015
14,376
5,855
64,895
85,126
Income (loss) from operations
$ ( 317,513 )
$ ( 24,140 )
$ ( 341,653 )
$ 120,466
$ 23,852
$ ( 197,335 )
Other income
174,303
Income tax expense
-
Loss from continuing operations
$ ( 23,032 )
18
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Segment Operations, Excluding Discontinued Operations
Antimony
Antimony
Total
Precious
For the six months ended June 30, 2024
USA
Mexico
Antimony
Metals
Zeolite
Total
Total revenues
$ 4,043,163
$ -
$ 4,043,163
$ 4,616
$ 1,597,391
$ 5,645,170
Depreciation and amortization
27,988
8,048
36,036
11,709
172,888
220,633
Income (loss) from operations
$ 356,897
$ ( 52,393 )
$ 304,504
$ ( 7,093 )
$ ( 579,761 )
$ ( 282,350 )
Other income
$ 312,747
Income tax expense
-
Income from continuing operations
$ 30,397
Segment Operations, Excluding Discontinued Operations
Antimony
Antimony
Total
Precious
For the six months ended June 30, 2023
USA
Mexico
Antimony
Metals
Zeolite
Total
Total revenues
$ 2,964,344
$ -
$ 2,964,344
$ 242,433
$ 1,269,184
$ 4,475,961
Depreciation and amortization
18,641
8,039
26,680
11,709
116,069
154,458
Income (loss) from operations
$ ( 255,441 )
$ ( 51,989 )
$ ( 307,430 )
$ 230,724
$ ( 40,753 )
$ ( 117,459 )
Other income
387,808
Income tax expense
-
Income from continuing operations
$ 270,349
NOTE 11 – DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE
As described in Note 1 , on March 11, 2024, the Company shut down the operations of USAMSA, which was part of the antimony segment, and announced its plans to sell its USAMSA subsidiary over the next year. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. Accordingly, our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows report discontinued operations separate from continuing operations for all periods presented. Our Condensed Consolidated Statements of Equity combine the results of continuing and discontinued operations. In addition, the Notes to Condensed Consolidated Financial Statements exclude discontinued operation for all periods presented.
Also as described in Note 1 , in May 2024, the Company made the decision to sell the personal residence it owns in Idaho that was previously used for management located near its BRZ operation (“BRZ Home”), which is part of the zeolite segment. The Company also signed an agreement with a realtor in May 2024 to assist with the sale of its BRZ Home. An active search for a buyer began after signing the agreement with the realtor and the Company expects the BRZ Home to be sold sometime over the next year. This sale of the BRZ Home did not meet the accounting requirements to report the BRZ Home as a discontinued operation but did meet the criteria to be reported as an asset held for sale in the second quarter of 2024. Accordingly, our Condensed Consolidated Balance Sheets report the $ 297,873 net book value of the BRZ Home in “Noncurrent assets held for sale” at June 30, 2024, while the prior period in our Condensed Consolidated Balance Sheets does not reflect this reclassification of the BRZ Home to “Noncurrent assets held for sale” at December 31, 2023. There were no other significant assets or liabilities related to the BRZ Home at June 30, 2024. In addition, the BRZ Home continues to be reported with continuing operation in our Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Cash Flows, and Condensed Consolidated Statements of Equity. However, there were no significant amounts in the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Cash Flows related to the BRZ Home. Also, no gain or loss has been recorded related to the BRZ Home since the decision was made to sell it.
19
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
The key components of the income (loss) from discontinued operations for the three and six months ended June 30, 2024 and 2023 were as follows:
For the three months ended
For the six months ended
June 30, 2024
June 30, 2023
June 30, 2024
June 30, 2023
REVENUES
$ 849,197
$ 238,456
$ 1,089,874
$ 238,456
COST OF REVENUES
507,615
329,119
981,711
1,259,381
GROSS PROFIT (LOSS)
341,582
( 90,663 )
108,163
( 1,020,925 )
OPERATING EXPENSES:
General and administrative
25,508
23,946
70,400
38,269
Professional fees
19,179
62,142
54,330
100,944
Other operating expenses
27,283
136,003
115,529
244,348
TOTAL OPERATING EXPENSES
71,970
222,091
240,259
383,561
INCOME (LOSS) FROM OPERATIONS
269,612
( 312,754 )
( 132,096 )
( 1,404,486 )
OTHER EXPENSE:
Other miscellaneous expense
( 11,116 )
( 679 )
( 18,277 )
( 9,312 )
TOTAL OTHER EXPENSE
( 11,116 )
( 679 )
( 18,277 )
( 9,312 )
INCOME (LOSS) FROM DISCONTINUED OPERATIONS, BEFORE TAX
258,496
( 313,433 )
( 150,373 )
( 1,413,798 )
Income tax expense
-
-
-
-
INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX
$ 258,496
$ ( 313,433 )
$ ( 150,373 )
$ ( 1,413,798 )
Depreciation and amortization expense of USAMSA totaled $nil for the three and six months ended June 30, 2024, and $ 155,974 and $ 310,883 for the three and six months ended June 30, 2023, respectively.
20
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Capital expenditures of USAMSA were $nil for the three and six months ended June 30, 2024, and $ 38,754 and $ 152,322 for the three and six months ended June 30, 2023, respectively.
The carrying amounts of major classes of assets and liabilities of USAMSA and BRZ Home included in assets and liabilities of discontinued operations were as follows:
June 30, 2024
USAMSA
BRZ Home
Total
ASSETS
CURRENT ASSETS
Accounts receivable
$ 45,936
$ -
$ 45,936
Inventories, net
-
-
-
Prepaid expenses
4,862
-
$ 4,862
Total current assets, discontinued operations
50,798
-
50,798
Properties, plants and equipment, net
5,689,446
297,873
5,987,319
IVA receivable and other assets, net
456,262
-
456,262
Total assets, discontinued operations
6,196,506
297,873
6,494,379
LIABILITIES
CURRENT LIABILITIES
Accounts payable
$ 130,807
$ -
$ 130,807
Accrued liabilities
15,123
-
15,123
Total current liabilities, discontinued operations
145,930
-
145,930
Asset retirement obligations
536,466
-
536,466
Total liabilities, discontinued operations
$ 682,396
$ -
$ 682,396
December 31, 2023
USAMSA
BRZ Home
Total
ASSETS
CURRENT ASSETS
Inventories, net
$ 366,955
$ -
$ 366,955
Total current assets, discontinued operations
366,955
-
366,955
Properties, plants and equipment, net
5,689,446
-
5,689,446
IVA receivable and other assets, net
491,139
-
491,139
Total assets, discontinued operations
$ 6,547,540
$ -
$ 6,547,540
LIABILITIES
CURRENT LIABILITIES
Accounts payable
$ 126,788
$ -
$ 126,788
Accrued liabilities
24,500
-
24,500
Total current liabilities, discontinued operations
151,288
-
151,288
Asset retirement obligations
536,466
-
536,466
Total liabilities, discontinued operations
$ 687,754
$ -
$ 687,754
21
Table of Contents
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
June 30, 2024
Mexico Tax Assessment
In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $ 13.8 million pesos, which was approximately $ 666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The assessment was settled in 2018 with no assessment due from the Company.
In early 2019, the Company was notified that SAT re-opened its assessment of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $ 16.3 million pesos, which was approximately $ 795,000 USD as of December 31, 2021.
Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believes the findings have no merit. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. The Company posted a guarantee of the amount in March 2020 as is required under the appeal process. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments. In 2022, the Mexican court ruled against the Company in the above matter. The Company subsequently appealed the ruling.
As of December 31, 2023, the updated SAT assessment was approximately $ 22.4 million pesos, or approximately $ 1,320,000 USD, which includes $ 352,000 of unpaid income taxes and $ 968,000 of interest and penalties. Management, along with its legal counsel, assessed the possible outcomes for this tax audit and believes, based on discussions with its attorneys located in Mexico, that the most likely outcome will be that the Company will be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at December 31, 2023 or December 31, 2022 relating to this potential tax liability.
In March 2024, Mexico’s appellate court ruled in favor of the Company with no assessment due related to this audit of USAMSA’s 2013 income tax return by SAT and instructed the lower court to issue a new ruling. In May 2024, Mexico’s lower court issued a final ruling on this matter in favor of the Company releasing any requirement for a guarantee on this matter from the Company but left open the possibility for the SAT to re-open their audit. These rulings support the Company’s position on this tax matter and had no impact on the Company’s financial statements at June 30, 2024.
Mexico Value Added Tax
USAMSA records a receivable for the Value Added Tax (“VAT” or “IVA”) it pays on certain goods and services representing amounts to be reimbursed from the Mexican government. This receivable balance of $ 1,053,966 and $ 1,122,628 at June 30, 2024 and December 31, 2023, respectively, is recorded in “IVA receivable and other assets, net” in USAMSA’s assets held for sale in discontinued operations net of a reserve of $ 653,749 and $ 687,534 at June 30, 2024 and December 31, 2023, respectively.
22
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.